“…Whereas many pathologic processes intrinsic to the globe may be easily evaluated under direct visualization, radiological imaging is of greater value in the evaluation of orbital and intracranial processes. In current practice, imaging including CT and MRI is the gold standard for diagnosis and management [28][29][30][31] (Tables 10.2 Complete blood count (CBC) and clotting studies including prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombin time (TT), to assess blood clotting function of the patient Tests to diagnose cancer at the time of biopsy Frozen-section, histopathology, immunohistochemistry, Immunophenotyping Flow-cytometry, DNA sequencing and antibody/gene microarray, PCR, quantitative PCR Tests to make a management plan Confirmation of tumor type and staging for chemo and radiation treatments Tests to determine the dissemination of cancer; sentinel node biopsy; LP cytology; BM biopsy Tumor marker tests to measure the presence, levels, or activity of specific proteins or genes in tissue and blood that may indicate the presence of cancer. A tumor that shows greater than normal level of a certain tumor marker may respond to treatment with a drug targeting that specific marker Tests to monitor the patient during treatment and look for adverse effects of the treatment Urinalysis; CBC; blood chemistry; tests detect metabolites, electrolytes, fats, and proteins, and enzymes including blood urea nitrogen (BUN) and creatinine and many others Tests to determine whether the tumor is responding to treatment and tests to monitor recurrence Clinical Laboratory tests can be useful for orbital tumor patient for numerous purposes.…”